OSTEOPOROSIS, POSTMENOPAUSAL
Clinical trials for OSTEOPOROSIS, POSTMENOPAUSAL explained in plain language.
Never miss a new study
Get alerted when new OSTEOPOROSIS, POSTMENOPAUSAL trials appear
Sign up with your email to follow new studies for OSTEOPOROSIS, POSTMENOPAUSAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Osteoporosis drug switch: can zoledronate stop bone loss after denosumab?
Disease control OngoingThis study looks at whether the drug zoledronate can prevent bone loss in postmenopausal women who stop taking denosumab, a common osteoporosis treatment. About 200 women who have been on denosumab for at least two years will receive zoledronate infusions at different times. The …
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo therapy aims to strengthen bones in elderly women
Disease control OngoingThis study tests whether giving older women (65+) in long-term care a monthly bone-building injection for one year, followed by an annual infusion, can improve bone density and prevent fractures. The goal is to find a better way to manage osteoporosis and reduce fracture risk in …
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Susan L. Greenspan • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Osteoporosis Exercise-Drug combo study pulled before starting
Knowledge-focused TerminatedThis study was designed to test whether adding arm exercises to a standard osteoporosis medication could improve bone density in the wrist. It was planned for postmenopausal women at high fracture risk, but was withdrawn before enrolling anyone. No results are available.
Matched conditions: OSTEOPOROSIS, POSTMENOPAUSAL
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC